N-Formyl Peptide Receptor 3 (FPR3) Departs from the Homologous FPR2/ALX Receptor with Regard to the Major Processes Governing Chemoattractant Receptor Regulation, Expression at the Cell Surface, and Phosphorylation
Marie‐Josèphe Rabiet(Centre National de la Recherche Scientifique), François Boulay(Université Grenoble Alpes), Cláes Dahlgren(Centre for Inflammation Research), Laurence Macari(Centre National de la Recherche Scientifique)
Cited by 65
Related Papers
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils.
|The Journal of Immunology|1995|314
Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes
|Infection and Immunity|1983|244